je.st
news
a step closer to a cure: Gilead seeks Fda Ok of oral attack on hepatitis C
2014-02-11 01:15:09| Biotech - Topix.net
Gilead Chief Scientific Officer Norbert Bischofberger: Combination treatment moves company one step closer to an all-oral cure for hepatitis C. Gilead Sciences Inc. asked U.S. regulators Monday to approve what could be the first oral treatment for most hepatitis C patients.
Tags: on
c
step
attack
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||